Displaying 21 to 40 of 90 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. |
United States | 31 Dec 2003 | N/A Initial investment. Round participant. Active |
|
|
|
BDNA Corp |
United States | 1 Oct 2007 | Series D Initial investment. Round participant. Active |
|
|
|
Bind Biosciences Inc Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue |
United States | 27 Nov 2007 | Series B Initial investment. Round participant. Active |
|
|
Bizo Inc A business audience marketing company. |
United States | 31 Dec 2008 | N/A Initial investment. Round participant. Active |
|
|
Black Duck Software Inc Software company focused on providing strategy, products, and services for enabling enterprise scale adoption of open source software (OSS). |
United States | 26 Jul 2004 | Series A Initial investment. Round participant. Active |
|
|
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | 7 Jan 2015 | Series B Follow-on investment. Round participant. Active |
|
|
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | 6 Jan 2012 | Series A Initial investment. Round participant. Active |
|
|
|
Brainshark Inc A multimedia company focused on delivering solutions for rich-media communication. |
United States | 31 Dec 1999 | N/A Initial investment. Round participant. Active |
|
|
|
Breathable Foods Inc A company pioneering novel devices and formulations for the delivery of nutrients and pharmaceuticals through breathing. |
United States | 31 Dec 2011 | N/A Initial investment. Round participant. Active |
|
|
|
Carbon Design Systems Inc Software company in the electronic design solutions market. |
United States | 31 Dec 2002 | N/A Initial investment. Round participant. Active |
|
|
|
Celera Corp A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases |
United States | 31 Dec 1998 | N/A Initial investment. Round participant. Active |
|
|
|
Cesura Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. |
United States | 31 Dec 2001 | N/A Initial investment. Round participant. Active |
|
|
|
Chantry Networks Inc IP-based wireless LAN (WLAN) solutions company. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
ChemGenics Pharmaceuticals Inc A biopharmaceutical company focused on genetically directed drug discovery focused on fungal bacterial diseases. |
United States | 31 Dec 1992 | N/A Initial investment. Round participant. Active |
|
|
|
Chinook Communications |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Color Kinetics Inc A company pioneering in the design, marketing and licensing of intelligent solid-state lighting systems. |
United States | 31 Dec 1997 | N/A Initial investment. Round participant. Active |
|
|
|
Compound Therapeutics Inc Biotechnology company focused on protein-based drugs. |
United States | 1 Mar 2003 | Series A Initial investment. Round participant. Active |
|
|
|
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | 30 Nov 2006 | Series B Initial investment. Round participant. Active |
|
|
|
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | 1 Apr 2008 | Series C Initial investment. Round participant. Active |